A Pipeline for Mapping FDA-Approved Nucleic Acid Amplification Tests (NAATs) to NCBI Taxonomy
Background The United States Food and Drug Administration (FDA) catalogs in vitro diagnostics, including Nucleic Acid Amplification Tests (NAATs), using unstructured clinical terminology. Because these regulatory labels often diverge from standardized biological taxonomy, they obstruct automated post-market surveilla...